Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ING Groep NV (ING) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

ING Groep NVTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

ING Groep NV vs Intuitive Surgical, Inc. — how do they compare? ING Groep NV trades at $32.22 (market cap $92.65B), while Intuitive Surgical, Inc. trades at $351.23 (market cap $125.08B). The key difference: Intuitive Surgical, Inc. is the larger of the two by market cap, and ING Groep NV pays a 3.93% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

INGISRG
Market Cap
$92.65B$125.08B
Sector
FinancialsHealth
52-Week High
$33.31$592.85
52-Week Low
$22.71$345.42
Dividend Yield
3.93%
Enterprise Value
$116.45B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ING Groep NV

ING trades at $33.11, up 2.41% today, with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $0.63, beating expectations, and maintains a net income margin of 27.84%. Analyst consensus is strongly positive with 62.5% buy ratings. Recent news highlights strategic moves like a 40% stake acquisition in Spain's Singular Bank and a new subscription banking model to diversify revenue.

The outlook for ING is favorable, supported by consistent earnings beats and strategic initiatives. Key risks include volatile cash flows, with negative operating cash flow in 2024, and exposure to European banking sector challenges. The stock presents a value opportunity with a P/E of 12.91, but investors should monitor execution of new growth strategies.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $350.06, down 1.34% on the day and near its 52-week low of $344.55. The stock is in a bearish technical trend despite strong fundamentals: Q2 2026 EPS beat estimates at $2.80 vs. $2.48 expected, revenue grew to $10.06B in 2025, and net income margin expanded to 28.45%. However, slowing U.S. procedure growth and a cautious 2026 outlook have pressured shares, with recent news highlighting a nearly 40% decline year-to-date.

The outlook remains mixed: robust profitability and a 69.6% analyst buy rating with a $504.56 consensus target suggest long-term value, but near-term risks include valuation concerns (P/E 40.5), competitive pressures, and macroeconomic headwinds. Investors face a divergence between solid execution and market sentiment driven by growth deceleration fears.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ING Groep NV

The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.

Read more on ING

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG